13 December 2019

Contents

Editorial

• i-Base 2019 appeal: we need your help….

• HTB 13 December 2019 online

Supplements

• Introduction to ART – October 2019

• UK Guide to PrEP – November 2019

Conference reports

• 17th European AIDS Conference (EACS 2019)

• Capsid inhibitor GS-6207 (lenacapavir): potential for 6 monthly dosing for MDR HIV

• Dolutegravir/lamivudine as dual ART

• Weight changes with doravirine-based first line therapy

• Bone and renal changes in the ADVANCE trial

• 10th International Workshop on HIV and Ageing

• Impact of isolation and loneliness on older people living with HIV

Antiretrovirals

• Doravirine approved by NHS England as single NNRTI and as part of FDC with 3TC/TDF

• Fostemsavir submitted to US FDA for multidrug resistant HIV

• Paediatric dispersible formulation of dolutegravir submitted to EMA and FDA

Lipodystrophy and metabolic complications

• Tesamorelin for NAFLD in people living with HIV

PDFs

• 13 December 2019 vol 20 no 14